Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This condition affects approximately 25-30% of US adults and is closely linked to obesity, type 2 diabetes, insulin resistance, and metabolic syndrome
Patients who choose oral tirzepatide should do so under medical supervision with a clear understanding that compounded formulations have less clinical data than FDA-approved injections
Improves insulin sensitivity at the cellular level Reduces appetite and food noise Targets visceral (belly) fat specifically Often improves other PCOS symptoms Beyond Weight Loss: PCOS Symptom Improvement Losing weight with PCOS doesn't just improve how you lookit can improve the entire syndrome
Compounded Tirzepatide: Compounded medicines do not have the same strict FDA approval process
US$ 26.60
US$ 29.69
US$ 22.10
US$ 21.14
